Stabilized recombinant trefoil factor 2 (TFF2-CTP) enhances anti-tumor activity of PD-1 blockade in mouse models of colorectal cancer

被引:0
作者
Kim, Woosook [1 ]
Fu, Na [1 ]
Duddempudi, Phaneendra [2 ]
Dubeykovskaya, Zinaida [3 ]
Almo, Steven [2 ]
Guha, Chandan [2 ]
Lederman, Seth [4 ]
Wang, Timothy [1 ]
机构
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Albert Einstein Coll Med, New York, NY USA
[3] NYU, New York, NY USA
[4] Tonix Pharmaceut Inc, New York, NY USA
关键词
D O I
10.1158/1538-7445.AM2020-6640
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6640
引用
收藏
页数:2
相关论文
共 50 条
[41]   Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer [J].
WANG Ting ;
WU Linguangjin ;
WANG Shuyun ;
SHI Xiaolan ;
LIU Hui ;
DENG Wanli .
Chinese Journal of Natural Medicines, 2023, 21 (05) :333-345
[42]   Oncolytic adenovirus H101 enhances the anti-tumor effects of PD-1 blockade via CD47 downregulation in tumor cells [J].
Qiao, Chenxiao ;
Xu, Yipeng ;
Cai, Zhijian ;
He, Yedie ;
Wang, Hua .
ONCOLOGY RESEARCH, 2025, 33 (05) :1161-1172
[43]   NKG2A immune checkpoint blockade enhances the anti-tumor efficacy of PD1/PD-L1 inhibitors in a preclinical model [J].
Sola, Caroline ;
Arnoux, Thomas ;
Chanuc, Fabien ;
Fuseri, Nicolas ;
Rossi, Benjamin ;
Gauthier, Laurent ;
Leget, Corinne ;
Bonnafous, Cecile ;
Wagtmann, Nicolai ;
Morel, Yannis ;
Andre, Pascale .
CANCER RESEARCH, 2016, 76
[44]   SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade (vol 9, pg 304, 2019) [J].
Zhao, Mingxia ;
Guo, Wenjie ;
Wu, Yuanyuan ;
Yang, Chenxi ;
Zhong, Liang ;
Deng, Guoliang ;
Zhu, Yuyu ;
Liu, Wen ;
Gu, Yanhong ;
Lu, Yin ;
Kong, Lingdong ;
Meng, Xiangbao ;
Xu, Qiang ;
Sun, Yang .
ACTA PHARMACEUTICA SINICA B, 2025, 15 (05) :2810-2812
[45]   Myeloid-Specific SHP-2 Ablation Induces Robust Anti-Tumor Immunity That Is Not Further Enhanced By PD-1 Blockade [J].
Christofides, Anthos ;
Tijaro-Ovalle, Natalia M. ;
Aksoylar, Halil-Ibrahim ;
Pal, Rinku ;
Mahmoud, Abdelrahman Aa ;
Strauss, Laura ;
Patsoukis, Nikolaos ;
Boussiotis, Vassiliki A. .
BLOOD, 2020, 136
[46]   Evaluating anti-tumor activity of the human anti-PD-1 antibody pembrolizumab using humanized mouse models [J].
Linn, Douglas E. ;
Cristescu, Razvan ;
Ray, Kallol ;
Zhang, Shuli ;
Dhandapani, Sripriya ;
Kaliyaperumal, Sarav ;
Yearley, Jennifer H. ;
Long, Brian J. .
CANCER RESEARCH, 2017, 77
[47]   Improved survival with erdafitinib (JNJ-42756493) and PD-1 blockade mediated by enhancement of anti-tumor immunity in an FGFR2-driven genetically engineered mouse model of lung cancer [J].
Palakurthi, Sangeetha ;
Kuraguchi, Mari ;
Zacharek, Sima ;
Liu, Jeff ;
Bonal, Dennis ;
Huang, Wei ;
Depeaux, Kristin ;
Dhaneshwar, Abha ;
Regan, Sam ;
Bailey, Dyane ;
Gowaski, Martha ;
Zheng, Mei ;
Bronson, Roderick ;
Ferrante, Catherine ;
Zudaire, Enrique ;
Laquerre, Sylvie ;
Bittinger, Mark ;
Paul, Kirschmeier ;
Packman, Kathryn ;
Verona, Raluca I. ;
Wong, Kwok-Kin ;
Lorenzi, Matthew V. .
CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
[48]   Armoring CAR-T therapy with PD-1 blockade: a powerful strategy for enhancing anti-tumor effects in pancreatic cancer [J].
Zhang, Zhixiang ;
Huang, Jingwei ;
Zhao, Zhifeng ;
Wang, Xiangyi ;
He, Cnhui ;
Yang, Sen ;
Gu, Qingyang .
CANCER RESEARCH, 2024, 84 (06)
[49]   Staged anti-PD-1 therapy with intratumoral recombinant calreticulin improves anti-tumor immunity and survival in glioblastoma mouse models [J].
Taori, Suchet ;
Noffsinger, Breanna ;
Miller, Charlotte A. ;
Xiao, Aizhen ;
Manigat, Laryssa ;
Zhong, Qing ;
Harris, Tajie ;
Purow, Benjamin .
CANCER RESEARCH, 2022, 82 (12)
[50]   Treatment with a VEGFR-2 antibody results in intra-tumor immune modulation and enhances anti-tumor efficacy of PD-L1 blockade in syngeneic murine tumor models [J].
Li, Yanxia ;
Amaladas, Nelusha ;
O'Mahony, Marguerita ;
Manro, Jason R. ;
Inigo, Ivan ;
Li, Qi ;
Rasmussen, Erik R. ;
Brahmachary, Manisha ;
Doman, Thompson N. ;
Hall, Gerald ;
Kalos, Michael ;
Novosiadly, Ruslan ;
Puig, Oscar ;
Pytowski, Bronislaw ;
Schaer, David A. .
PLOS ONE, 2022, 17 (07)